MAGE-A12 ANTIGENIC PEPTIDES AND USES THEREOF - Patent 1222274

(19)

(11)

EP 1 222 274 A2

(12)

(88)	Date of publication A3:
	07.03.2002

(43)	Date of publication:
	17.07.2002 Bulletin 2002/29

(21)	Application number: 00975282.5

(22)	Date of filing: 19.10.2000

(51)	International Patent Classification (IPC)⁷: C12N 15/12, C07K 14/47, A61K 38/17, G01N 33/53, C07K 16/18, C12N 5/06, A61K 39/00, A61K 35/14

(86)	International application number:
	PCT/US0028/852

(87)	International publication number:
	WO 0129/220 (26.04.2001 Gazette 2001/17)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

19.10.1999 US 160374 P
01.02.2000 US 179570 P

(71)	Applicant: LUDWIG INSTITUTE FOR CANCER RESEARCH
	New York,New York 10158 (US)

(72)	Inventors:
	HEIDECKER, Leonora B-1200 Brussels (BE) VAN DEN EYNDE, Benoit B-1200 Brussels (BE) BOON-FALLEUR, Thierry B-1200 Brussels (BE) BRASSEUR, Francis B-1200 Brussels (BE)

(74)	Representative: Harrison Goddard Foote
	31 St Saviourgate York Y01 8NQ York Y01 8NQ (GB)

(54)	MAGE-A12 ANTIGENIC PEPTIDES AND USES THEREOF